Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04178746 · ClinicalTrials.gov registry record
PRONTO: Artemis in the Removal of Intraventricular Hemorrhage in the Hyper-Acute Phase
A clinical trial, sponsored by Penumbra.
- Terminated
- Registry status
- 4
- Enrollment target
NCT04178746: Clinical Trial study, sponsored by Penumbra.
NCT04178746 is a clinical trial that was terminated before completion, run by Penumbra. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04178746 was terminated before completion, sponsored by Penumbra.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
The purpose of this prospective, single center, single arm registry is to assess technical feasibility, peri-procedural complications, post-procedure imaging outcomes, and 30-day safety outcomes in subjects with intraventricular hemorrhages utilizing the Artemis Neuro Evacuation Device in the hyper-acute phase.
Primary Outcome
Post-Procedural Hemorrhage reduction of ≥ 85% in hemorrhage volume assessed by CT at 24 hours
Interventions
- DEVICE Artemis Neuro Evacuation Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-09-26 |
| Est. Completion | 2021-06-02 |
Why NCT04178746 stopped before completion
NCT04178746 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Artemis Neuro Evacuation Device is the first listed.
NCT04178746 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04178746 about?
NCT04178746 is a clinical study titled "PRONTO: Artemis in the Removal of Intraventricular Hemorrhage in the Hyper-Acute Phase". The purpose of this prospective, single center, single arm registry is to assess technical feasibility, peri-procedural complications, post-procedure imaging outcomes, and 30-day safety outcomes in subjects with intraventricular hemorrhages utilizing the Artemis Neuro Evacuation Device in the hyper-...
What is the current status of trial NCT04178746?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2019-09-26. Estimated completion is 2021-06-02.
What interventions are being tested in trial NCT04178746?
The interventions under investigation include: Artemis Neuro Evacuation Device (DEVICE).
Who is sponsoring clinical trial NCT04178746?
This trial is sponsored by Penumbra, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI